Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros (BME:LDA) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Simply Wall St

Last week saw the newest half-yearly earnings release from Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros (BME:LDA), an important milestone in the company's journey to build a stronger business. The results were positive, with revenue coming in at €609m, beating analyst expectations by 7.0%. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

BME:LDA Earnings and Revenue Growth July 30th 2026

Taking into account the latest results, Línea Directa Aseguradora Compañía de Seguros y Reaseguros' seven analysts currently expect revenues in 2026 to be €1.21b, approximately in line with the last 12 months. Per-share earnings are expected to expand 12% to €0.097. In the lead-up to this report, the analysts had been modelling revenues of €1.19b and earnings per share (EPS) of €0.091 in 2026. So the consensus seems to have become somewhat more optimistic on Línea Directa Aseguradora Compañía de Seguros y Reaseguros' earnings potential following these results.

See our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros

The consensus price target was unchanged at €1.45, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Línea Directa Aseguradora Compañía de Seguros y Reaseguros analyst has a price target of €1.60 per share, while the most pessimistic values it at €1.15. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Línea Directa Aseguradora Compañía de Seguros y Reaseguros shareholders.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Línea Directa Aseguradora Compañía de Seguros y Reaseguros' revenue growth is expected to slow, with the forecast 2.2% annualised growth rate until the end of 2026 being well below the historical 5.2% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 5.5% per year. Factoring in the forecast slowdown in growth, it seems obvious that Línea Directa Aseguradora Compañía de Seguros y Reaseguros is also expected to grow slower than other industry participants.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Línea Directa Aseguradora Compañía de Seguros y Reaseguros following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €1.45, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Línea Directa Aseguradora Compañía de Seguros y Reaseguros analysts - going out to 2028, and you can see them free on our platform here.

Even so, be aware that Línea Directa Aseguradora Compañía de Seguros y Reaseguros is showing 1 warning sign in our investment analysis , you should know about...

Valuation is complex, but we're here to simplify it.

Discover if Línea Directa Aseguradora Compañía de Seguros y Reaseguros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.